Formation of a dimeric tungsten(i) complex via C-H activationDALTON TRANSACTIONSIF3.32020-01-015PREAI
Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesteraseEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92017-01-0139PREAI
Converting maslinic acid into an effective inhibitor of acylcholinesterasesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92015-10-0120PREAI
Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acidsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92015-08-0142PREAI
New antitumor 6-chloropurine nucleosides inducing apoptosis and G2/M cell cycle arrestEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92015-01-0113PREAI
Sulfamates of methyl triterpenoates are effective and competitive inhibitors of carbonic anhydrase IIEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92014-10-0125PREAI
Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterasesBIOORGANIC & MEDICINAL CHEMISTRYIF32014-07-0157PRE
A natural approach: Synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosidesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92014-01-0140PREAI
Synthesis and biological evaluation of novel (E) stilbene-based antitumor agentsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92012-08-0124PREAI
Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivativesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92011-11-0176PREAI
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acidEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92010-12-0162PREAI
Synthesis and antitumour activity of glycyrrhetinic acid derivativesBIOORGANIC & MEDICINAL CHEMISTRYIF32010-11-0184PRE
Synthesis and biological evaluation of antitumor-active γ-butyrolactone substituted betulin derivativesBIOORGANIC & MEDICINAL CHEMISTRYIF32010-04-0137PRE